目的:研究分析数字减影脑血管造影介入术患者治疗后并发症的发生类型以及护理干预措施.方法:共计抽取40例脑血管疾病患者作为研究对象,患者均于2019年3月至2019年9月入我院进行数字减影脑血管造影介入术治疗,统计患者手术后并发症的发生情况以及对护理工作的满意情况.结果:40例患者手术后并发症发生率为7.5％,对护理工作的满意度为97.5％.结论:穿刺点出血、血压降低以及肺部感染均是数字减影脑血管造影介入术治疗患者术后并发症的主要类型,临床治疗中需要根据患者的实际情况选择相适合的护理干预方式,做好并发症的预防护理,缓解患者痛苦,提升治疗安全性.
Objective To detect the effect and clinical significance of the serum level changes of nitric oxide (NO) and alpha granule membrane protein (GMP 140)in patients with coronary heart disease (CHD) Methods The serum levels of NO and GMP 140 were measured in 40 patients with CHD (22 patients with unstable angina,18 patients with stable angina) and 45 control subjects by Griess calorimetric method and enzyme linked immunosorbent assay Results ①Serum levels of NO were significantly lower in patients with CHD than those in control group ( P 0 01) ②Serum levels of NO were significantly lower in patients with unstable angina than those in stable angina,serum levels of GMP 140 were significantly higher than those in stable angina ③Negative correlation was present between the NO and GMP 140 ( P 0 01) Conclusion The result shows that serum levels of NO and GMP 140 play an important role in the happening and development of CHD;measuring the serum of NO and GMP 140 is helpful for indicating the severity of CHD and its therapeutic effect
<span id="ChDivSummary" name="ChDivSummary" class="abstract-text">本文根据WHO1993年诊断标准,对154例原发性高血压患者进行了生物反馈观察[1],其中抵抗性高血压13例、轻中度高血压17例。将一般原发性高血压124例,随机分为反馈组62例与对照组62例,两组患者年龄、性别、临床类型、病程、家族史等经卡方检验差异无显著性。采用PW-1A型皮温?..</span>
目的 观察皮温生物反馈疗法治疗高血压病的效果。方法 将154例高血压病患者分为反馈组、对照组各62例及减（停）药组30例。反馈组、减药组应用皮温生物反馈治疗并放松训练,参照动态血压监测（ABPM）提示的血压高峰值,进行高峰前反馈的时间治疗。结果 在反馈治疗92例中,73例不同程度地减少乃至停用了降压药物,其中反馈组47例、减药组26例（9例停用了降压药）。结论 皮温反馈法不仅可作为Ⅰ期高血压病与临界高血压的首选疗法,也是Ⅱ、Ⅲ期高血压病的重要辅助疗法
